Conventional oxygen therapy (COT) and noninvasive ventilation (NIV) have been
considered for decades as frontline treatment for acute or chronic respiratory failure …

Background: Use of high-flow nasal oxygen (HFNO) for treatment of adults with acute
respiratory failure (ARF) has increased. Purpose: To assess HFNO versus noninvasive …

Rationale: How to provide advanced respiratory support for coronavirus disease (COVID-19)
to maximize population-level survival while optimizing mechanical ventilator access is …

Mechanical ventilation (MV) is an essential part of modern intensive care medicine. MV is
performed in patients with severe respiratory failure caused by respiratory muscle …

Objectives Continuous positive airway pressure (CPAP) is an effective treatment of severe
obstructive sleep apnea (OSA) but poor compliance is a major limitation. High-flow nasal …

COVID-19 patients with acute hypoxemic respiratory failure (AHRF) benefit from high flow
nasal cannula (HFNC) oxygen therapy. However, delays in initiating invasive ventilation …

Background Acute respiratory failure (ARF) is a common cause of presentation to the
Emergency Department (ED). High flow nasal cannula (HFNC) has been introduced as an …

Acute hypoxemic respiratory failure is the principal cause of hospitalization, invasive
mechanical ventilation and death in severe COVID-19 infection. Nearly half of intubated …

BACKGROUND: High-flow nasal cannula (HFNC) oxygen therapy is a routine, evidence-
based treatment in the ICU. Due to its ease of application, non–evidence-based use of …

Bronchiolitis is the most common reason for infants to be hospitalised. Over the past decade,
the use of high‐flow nasal cannulae (HFNC) therapy has increased markedly and it is now …